These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
586 related articles for article (PubMed ID: 9565761)
21. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons. Melo JB; Sousa C; Garção P; Oliveira CR; Agostinho P Eur J Neurosci; 2009 Feb; 29(3):455-64. PubMed ID: 19222556 [TBL] [Abstract][Full Text] [Related]
22. Melatonin oxidative stress and neurodegenerative diseases. Srinivasan V Indian J Exp Biol; 2002 Jun; 40(6):668-79. PubMed ID: 12587715 [TBL] [Abstract][Full Text] [Related]
23. The molecular basis of the prevention of Alzheimer's disease through healthy nutrition. Steele M; Stuchbury G; Münch G Exp Gerontol; 2007; 42(1-2):28-36. PubMed ID: 16839733 [TBL] [Abstract][Full Text] [Related]
24. Antioxidant approaches for the treatment of Alzheimer's disease. Lee HP; Zhu X; Casadesus G; Castellani RJ; Nunomura A; Smith MA; Lee HG; Perry G Expert Rev Neurother; 2010 Jul; 10(7):1201-8. PubMed ID: 20586698 [TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity. Kim CY; Lee C; Park GH; Jang JH Arch Pharm Res; 2009 Jun; 32(6):869-81. PubMed ID: 19557365 [TBL] [Abstract][Full Text] [Related]
26. Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E. Fillenbaum GG; Kuchibhatla MN; Hanlon JT; Artz MB; Pieper CF; Schmader KE; Dysken MW; Gray SL Ann Pharmacother; 2005 Dec; 39(12):2009-14. PubMed ID: 16227448 [TBL] [Abstract][Full Text] [Related]
27. Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease. Feng Z; Qin C; Chang Y; Zhang JT Free Radic Biol Med; 2006 Jan; 40(1):101-9. PubMed ID: 16337883 [TBL] [Abstract][Full Text] [Related]
28. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275 [TBL] [Abstract][Full Text] [Related]
29. [Treatment of Alzheimer's disease]. López OL; Becker JT Rev Neurol; 2002 Nov 1-15; 35(9):850-9. PubMed ID: 12436384 [TBL] [Abstract][Full Text] [Related]
30. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease. Pedersen WA; McCullers D; Culmsee C; Haughey NJ; Herman JP; Mattson MP Neurobiol Dis; 2001 Jun; 8(3):492-503. PubMed ID: 11442356 [TBL] [Abstract][Full Text] [Related]
31. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease. Calabrese V; Butterfield DA; Stella AM Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484 [TBL] [Abstract][Full Text] [Related]
32. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease. Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525 [TBL] [Abstract][Full Text] [Related]
33. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Behl C Prog Neurobiol; 1999 Feb; 57(3):301-23. PubMed ID: 10096843 [TBL] [Abstract][Full Text] [Related]
34. Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity. Sozio P; D'Aurizio E; Iannitelli A; Cataldi A; Zara S; Cantalamessa F; Nasuti C; Di Stefano A Arch Pharm (Weinheim); 2010 Mar; 343(3):133-42. PubMed ID: 20186865 [TBL] [Abstract][Full Text] [Related]
35. Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents. Darvesh AS; Carroll RT; Bishayee A; Geldenhuys WJ; Van der Schyf CJ Expert Rev Neurother; 2010 May; 10(5):729-45. PubMed ID: 20420493 [TBL] [Abstract][Full Text] [Related]
36. Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease. Choi DY; Lee YJ; Hong JT; Lee HJ Brain Res Bull; 2012 Feb; 87(2-3):144-53. PubMed ID: 22155297 [TBL] [Abstract][Full Text] [Related]
37. [Influence of vascular comorbidities on the antioxidant defense system in Alzheimer's disease]. Polidori MC; Stahl W; De Spirt S; Pientka L Dtsch Med Wochenschr; 2012 Feb; 137(7):305-8. PubMed ID: 22318842 [TBL] [Abstract][Full Text] [Related]
38. More than the sum of its parts? Nutrition in Alzheimer's disease. von Arnim CA; Gola U; Biesalski HK Nutrition; 2010; 26(7-8):694-700. PubMed ID: 20381316 [TBL] [Abstract][Full Text] [Related]
39. Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. Bennett S; Grant MM; Aldred S J Alzheimers Dis; 2009; 17(2):245-57. PubMed ID: 19221412 [TBL] [Abstract][Full Text] [Related]
40. Withanamides in Withania somnifera fruit protect PC-12 cells from beta-amyloid responsible for Alzheimer's disease. Jayaprakasam B; Padmanabhan K; Nair MG Phytother Res; 2010 Jun; 24(6):859-63. PubMed ID: 19957250 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]